Results indicate that a regular intake of aloe barbadensis gel has helped reduce the levels of fasting blood sugar and glycated hemoglobin.
29/12/05 Japan, Morinaga Milk Industry has announced the results of its latest research on aloe barbadensis leaf. The company has conducted a trial that covers 70 people who are diagnosed as borderline diabetic.
The trial results indicate that a regular intake of aloe barbadensis gel has helped reduce the levels of fasting blood sugar and glycated hemoglobin. Accordingly, the company concludes that aloe barbadensis leaf may play a role in preventing and improving diabetes.
Details of the research will be presented at the 40th Annual Meeting of the Japan Society of Adult Diseases to be held in January 2006.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients










